Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Acquisitions (2020 - 2025)

Health Catalyst (HCAT) has disclosed Acquisitions for 6 consecutive years, with -$8000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Acquisitions fell 100.04% year-over-year to -$8000.0, compared with a TTM value of $66.5 million through Sep 2025, changed 0.33%, and an annual FY2024 reading of $80.3 million, up 604.68% over the prior year.
  • Acquisitions was -$8000.0 for Q2 2025 at Health Catalyst, down from $41.1 million in the prior quarter.
  • Across five years, Acquisitions topped out at $46.8 million in Q3 2021 and bottomed at -$8000.0 in Q2 2025.
  • Average Acquisitions over 5 years is $23.0 million, with a median of $18.7 million recorded in 2024.
  • The sharpest move saw Acquisitions skyrocketed 122.86% in 2024, then tumbled 100.04% in 2025.
  • Year by year, Acquisitions stood at $46.8 million in 2021, then plummeted by 80.03% to $9.3 million in 2022, then grew by 22.01% to $11.4 million in 2023, then skyrocketed by 122.86% to $25.4 million in 2024, then plummeted by 100.03% to -$8000.0 in 2025.
  • Business Quant data shows Acquisitions for HCAT at -$8000.0 in Q2 2025, $41.1 million in Q1 2025, and $25.4 million in Q4 2024.